U. D. Gündoğdu And f. Karabağ, "The Clinical Effect of Triglyceride Glucose index, aninsulin Resistance Marker, on Predicting Paclitaxel-induced Neuropathy," Eurasian Journal of Medical Investigation , vol.6, no.2, pp.180-183, 2022
Gündoğdu, U. D. And Karabağ, f. 2022. The Clinical Effect of Triglyceride Glucose index, aninsulin Resistance Marker, on Predicting Paclitaxel-induced Neuropathy. Eurasian Journal of Medical Investigation , vol.6, no.2 , 180-183.
Gündoğdu, U. D., & Karabağ, f., (2022). The Clinical Effect of Triglyceride Glucose index, aninsulin Resistance Marker, on Predicting Paclitaxel-induced Neuropathy. Eurasian Journal of Medical Investigation , vol.6, no.2, 180-183.
Gündoğdu, UTKU, And FUNDA KARABAĞ. "The Clinical Effect of Triglyceride Glucose index, aninsulin Resistance Marker, on Predicting Paclitaxel-induced Neuropathy," Eurasian Journal of Medical Investigation , vol.6, no.2, 180-183, 2022
Gündoğdu, UTKU D. And Karabağ, FUNDA. "The Clinical Effect of Triglyceride Glucose index, aninsulin Resistance Marker, on Predicting Paclitaxel-induced Neuropathy." Eurasian Journal of Medical Investigation , vol.6, no.2, pp.180-183, 2022
Gündoğdu, U. D. And Karabağ, f. (2022) . "The Clinical Effect of Triglyceride Glucose index, aninsulin Resistance Marker, on Predicting Paclitaxel-induced Neuropathy." Eurasian Journal of Medical Investigation , vol.6, no.2, pp.180-183.
@article{article, author={UTKU DÖNEM Gündoğdu And author={FUNDA KARABAĞ}, title={The Clinical Effect of Triglyceride Glucose index, aninsulin Resistance Marker, on Predicting Paclitaxel-induced Neuropathy}, journal={Eurasian Journal of Medical Investigation}, year=2022, pages={180-183} }